EUVIMEDEUVIMED entdecken
Open Access · CC0

Genomic ascertainment refines the population prevalence and phenotype associations of germline TERT variants

Marena R Niewisch, Sherifa A Akinniyi iD, Kelvin C de Andrade, Jung Kim iD, Logan P Zeigler iD, Jeremy S Haley iD, Gretchen Urban, David J Carey, Douglas R Stewart, Sharon A Savage iD

PLOS Genetics · 05.11.2026 · 22 (11) · e1012352

DOI: 10.1371/journal.pgen.1012352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Genetics, online erschienen am 05.11.2026. Verfasst von Marena R Niewisch und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Telomerase, Germ-Line Mutation. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Intramural NIH HHS, Division of Cancer Epidemiology and Genetics, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individuals with deleterious germline variants in telomerase (encoded by TERT ) are at high risk of pulmonary fibrosis (PF), liver disease (LD), bone marrow failure, head/neck squamous cell carcinoma (HNSCC), and other complications. Clinically ascertained cohorts are subject to biased ascertainment of affected individuals and families with early onset, complex disease. This study used genomic ascertainment to determine prevalence of deleterious TERT variants and the associated risks of telomere biology disorder (TBD) phenotypes.

Methods

TERT variants were extracted from exome sequencing data in UK Biobank (UKB, 469,377 exomes) and Geisinger-Regeneron DiscovEHR collaboration (DiscovEHR, 170,503 exomes). Cases were individuals with heterozygous deleterious TERT variants classified per modified ACMG/AMP criteria. Controls excluded rare, exonic, and splice site TERT variants. Electronic health records were assessed for TBD-related ICD10 codes. Case-control comparisons were done separately for UKB and DiscovEHR, accounting for smoking, alcohol, BMI, sex, genetic ancestry, and birthyear.

Results

There were 64 deleterious TERT variants in 203 UKB participants and 32 in 138 DiscovEHR participants. Prevalence estimates were 1:2,312 in UKB and 1:1,235 in DiscovEHR. Risk of PF was significantly increased for TERT heterozygotes compared with controls (UKB: odds ratio [OR] 10.9 95% confidence interval [CI]: 6.11-19.45, p < 0.001; DiscovEHR: OR 6.64, 95% CI: 3.31-13.3, p < 0.001). Deleterious TERT variants were also associated with higher risk of LD (OR 2.4, 95% CI:1.25-4.59, p = 0.038) and HNSCC (OR 5.75, 95% CI: 2.36-14.02, p = 0.001) in UKB but not in DiscovEHR.

Conclusions

Rare deleterious TERT variants were present in 0.04 to 0.08% of the populations studied. Genomic ascertainment shows a predominance of pulmonary phenotypes, with PF associated with deleterious TERT variants in both cohorts. Associations with LD and HNSCC were observed only in UKB, possibly reflecting cohort differences including healthy volunteer bias. These findings illustrate the clinical importance of genetic diagnosis, and need for TBD-specific clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseGerm-Line MutationHumansFemaleMalePhenotypePrevalenceMiddle AgedCase-Control StudiesGenetic Predisposition to DiseaseExome SequencingAgedAdultPulmonary FibrosisTelomereGenomics

Substanzen

TelomeraseTERT protein, human

Autor:innen und Institutionen

  • Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Cancer Genomics Research Laboratory, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Department of Genomic Health, Weis Center for Research, Geisinger Medical Center, Danville, Pennsylvania, United States of America.

ORCID-Profile: Sherifa A Akinniyi, Jung Kim, Logan P Zeigler, Jeremy S Haley, Sharon A Savage

Förderung

  • Intramural NIH HHS
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute

Zitieren

APA

Niewisch, M. R., Akinniyi, S. A., de Andrade, K. C., Kim, J., Zeigler, L. P., Haley, J. S., Urban, G., Carey, D. J., Stewart, D. R., & Savage, S. A. (2026). Genomic ascertainment refines the population prevalence and phenotype associations of germline TERT variants. PLOS Genetics, 22(11), e1012352. https://doi.org/10.1371/journal.pgen.1012352

Vancouver

Niewisch MR, Akinniyi SA, de Andrade KC, Kim J, Zeigler LP, Haley JS, et al. Genomic ascertainment refines the population prevalence and phenotype associations of germline TERT variants. PLOS Genetics. 2026;22(11):e1012352. doi:10.1371/journal.pgen.1012352

BibTeX
@article{Niewisch2026,
  author = {Niewisch, Marena R and Akinniyi, Sherifa A and de Andrade, Kelvin C and Kim, Jung and Zeigler, Logan P and Haley, Jeremy S and Urban, Gretchen and Carey, David J and Stewart, Douglas R and Savage, Sharon A},
  title = {Genomic ascertainment refines the population prevalence and phenotype associations of germline TERT variants},
  journal = {PLOS Genetics},
  year = {2026},
  volume = {22},
  number = {11},
  pages = {e1012352},
  doi = {10.1371/journal.pgen.1012352}
}
Kostenlos starten →